The Real-World Experience of the Biosimilar (grastofil®) to the Reference Biologic (neupogen®) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study.
Current oncology（2022）
关键词
biosimilar,breast cancer,lymphoma,primary prophylaxis,febrile neutropenia,retrospective study,Neupogen (R) and Grastofil (R)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要